Financial Daily from THE HINDU group of publications Tuesday, Apr 27, 2004 |
||
|
|
||
|
Corporate Results
-
Bio-tech & Genetics Sterling Biotech Q1 profit up 46.7 pc Our Bureau
Mumbai , April 26 STERLING Biotech, global manufacturer of pharmaceutical grade gelatine, has posted a 46.7 per cent growth in its profit after tax at Rs 15.04 crore for the quarter ended March 31 compared to Rs 10.25 crore in the first quarter of the corresponding period last year. Net sales at Rs 80.02 crore, registered a growth of 19 per cent from Rs 66.99 crore in the first quarter of the previous year. Mr Nitin Sandesara, Chairman, Sterling Biotech, said in a communication issued here on Monday: "A significant part of our revenue has come after the consolidation in gelatine business; this trend will further increase with our capacity expansion and optimal utilisation of newly acquired plant from Rallis India.''
More Stories on : Bio-tech & Genetics
Article E-Mail :: Comment :: Syndication :: Printer Friendly Page
|
Stories in this Section |
|
The Hindu Group: Home | About Us | Copyright | Archives | Contacts | Subscription Group Sites: The Hindu | Business Line | Sportstar | Frontline | The Hindu eBooks | The Hindu Images | Home |
Copyright © 2004, The
Hindu Business Line. Republication or redissemination of the contents of
this screen are expressly prohibited without the written consent of
The Hindu Business Line
|